Brendan Smith
Stock Analyst at TD Cowen
(4.91)
# 246
Out of 5,133 analysts
282
Total ratings
57.3%
Success rate
33.6%
Average return
Main Sectors:
Stocks Rated by Brendan Smith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TWST Twist Bioscience | Rated: Buy | $190 → $137 | $111.60 | +22.76% | 20 | Nov 13, 2026 | |
| AZTA Azenta | Reiterated: Hold | $33 → $50 | $45.65 | +9.53% | 13 | Nov 11, 2026 | |
| CTKB Cytek Biosciences | Reiterated: Hold | $5 | $5.84 | -14.38% | 13 | Nov 5, 2026 | |
| SDGR Schrödinger | Reiterated: Buy | $31 → $36 | $29.53 | +21.91% | 14 | Nov 5, 2026 | |
| WST West Pharmaceutical Services | Reiterated: Buy | $420 → $500 | $416.42 | +20.07% | 9 | Oct 29, 2026 | |
| CERT Certara | Reiterated: Buy | $9 → $11 | $11.57 | -4.93% | 11 | Oct 13, 2026 | |
| DNA Ginkgo Bioworks Holdings | Reiterated: Hold | $9 → $11 | $9.61 | +14.46% | 15 | Oct 13, 2026 | |
| HALO Halozyme Therapeutics | Rated: Buy | $105 → $130 | $100.27 | +29.65% | 25 | Oct 13, 2026 | |
| TKNO Alpha Teknova | Rated: Buy | $7 → $11 | $8.21 | +33.98% | 13 | Oct 13, 2026 | |
| MRVI Maravai LifeSciences Holdings | Initiated Coverage: Buy | $9 | $7.54 | +19.36% | 1 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.45 | - | 11 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $5 | $4.91 | +1.83% | 12 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.19 | - | 12 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $1.16 | +72.41% | 11 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.74 | - | 11 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.25 | - | 11 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $11.49 | - | 11 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.19 | - | 11 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $167.79 | +19.20% | 11 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 → $2 | $1.58 | +26.58% | 10 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2 | $27.61 | -92.76% | 1 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.651 | - | 7 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $47.78 | n/a | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $18.74 | n/a | 11 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $9 | $8.53 | n/a | 6 | Nov 12, 2024 |
Twist Bioscience
Nov 13, 2026
Rated: Buy
Price Target: $190 → $137
Current: $111.60
Upside: +22.76%
Azenta
Nov 11, 2026
Reiterated: Hold
Price Target: $33 → $50
Current: $45.65
Upside: +9.53%
Cytek Biosciences
Nov 5, 2026
Reiterated: Hold
Price Target: $5
Current: $5.84
Upside: -14.38%
Schrödinger
Nov 5, 2026
Reiterated: Buy
Price Target: $31 → $36
Current: $29.53
Upside: +21.91%
West Pharmaceutical Services
Oct 29, 2026
Reiterated: Buy
Price Target: $420 → $500
Current: $416.42
Upside: +20.07%
Certara
Oct 13, 2026
Reiterated: Buy
Price Target: $9 → $11
Current: $11.57
Upside: -4.93%
Ginkgo Bioworks Holdings
Oct 13, 2026
Reiterated: Hold
Price Target: $9 → $11
Current: $9.61
Upside: +14.46%
Halozyme Therapeutics
Oct 13, 2026
Rated: Buy
Price Target: $105 → $130
Current: $100.27
Upside: +29.65%
Alpha Teknova
Oct 13, 2026
Rated: Buy
Price Target: $7 → $11
Current: $8.21
Upside: +33.98%
Maravai LifeSciences Holdings
Oct 5, 2026
Initiated Coverage: Buy
Price Target: $9
Current: $7.54
Upside: +19.36%
Sep 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.45
Upside: -
Aug 17, 2026
Reiterated: Buy
Price Target: $3 → $5
Current: $4.91
Upside: +1.83%
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.19
Upside: -
Aug 11, 2026
Reiterated: Hold
Price Target: $2
Current: $1.16
Upside: +72.41%
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.74
Upside: -
Aug 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.25
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $11.49
Upside: -
Aug 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.19
Upside: -
Jul 28, 2026
Reiterated: Buy
Price Target: $200
Current: $167.79
Upside: +19.20%
Jul 15, 2026
Downgraded: Hold
Price Target: $4 → $2
Current: $1.58
Upside: +26.58%
Jul 14, 2026
Downgraded: Hold
Price Target: $2
Current: $27.61
Upside: -92.76%
May 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.651
Upside: -
May 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $47.78
Upside: n/a
May 6, 2025
Reiterated: Buy
Price Target: n/a
Current: $18.74
Upside: n/a
Nov 12, 2024
Reiterated: Hold
Price Target: $14 → $9
Current: $8.53
Upside: n/a